Bioiberica’s Glucosamine API is a high-quality, animal origin ingredient for the development of finished pharmaceutical formulations targeting osteoarthritis and joint discomfort. Our pharmaceutical grade Glucosamine API is manufactured under strict GMP quality standards and complies with US and EU Pharmacopoeias.
Glucosamine is a precursor for the synthesis of glycosaminoglycans (GAG), like hyaluronic acid – a component of most connective tissues and therefore important for joint health. Bioiberica’s Glucosamine API is available in the forms of:
As individuals age, their cartilage gradually deteriorates which can cause pain and discomfort. Glucosamine API is considered a Symptomatic Slow Acting Drug for mild knee osteoarthritis, helping to reduce joint pain and improve mobility.
Bioiberica is your partner of choice for innovation in the mobility market. Our knowledge in animal-derived Glucosamine API, plus our quality and technical support and regulatory expertise, enables manufacturers in the pharmaceutical space to bring their products to market faster and with enduring success.
Download our product information sheet to learn more about Glucosamine API and how Bioiberica is supporting the development of safe and effective mobility solutions for the pharma market.